Accrol Group Holdings plc is a leading independent tissue converter, manufacturing toilet rolls, kitchen rolls, facial tissues and AFH products to supply retailers throughout the UK. Accrol imports parent reels from around the world and converts them into finished goods at the Company’s 350,000 sq. ft. manufacturing, storage and distribution facility in Blackburn, Lancashire. Accrol currently manufactures approximately 17 million units per week and supplies some of the UK’s largest retailers.

Accrol Group Holdings plc is listed on AIM, the growth market of the London Stock Exchange.

The Company was incorporated and registered in England and Wales on 30 April 2014 under the Act with registered number 9019496 as a private company limited by shares with the name Aghoco 1220 Limited. The name of the Company was changed to Accrol Group Holdings Limited on 1 August 2014. The Company was re-registered as a public limited company with the name Accrol Group Holdings plc on 1st June 2016. Accrol Group Holdings plc’s main country of operation is the UK.

The Company, and the Group, trade under the name “Accrol Papers”.

Preliminary results for year ended 30 April 2017
RNS
RNS Number : 5118K
Accrol Group Holdings PLC
10 July 2017
 
This announcement contains inside information
10 July 2017
Accrol Group Holdings plc
Preliminary results for the twelve months ended 30 April 2017
 
Accrol Group Holdings plc, the AIM listed leading independent tissue converter, is pleased to announce its preliminary results for the twelve months to 30 April 2017.
 
Financial Highlights
 
·      Revenue increased 14.2% to £135.1m (FY16: £118.2m)
·      Gross Profit increased 9.3% to £37.7m (FY16: £34.5m)
·      Adjusted gross margin(1) was  27.9% (FY16: 28.1%) supported by favourable parent reel pricing and significant currency hedging
·      Adjusted EBITDA(1) increased 6.8% to £16.1m (FY16: £15.0m)
·      Adjusted profit after tax(1) increased 57.3% to £11.0m (FY16: £7.0m)
·      Profit after tax increased 29.3% to £7.4m (FY16: £5.7m)
·      Continued strong cash generation in a period which included a £3.6m repayment of loan note interest
·      Net debt reduced by £41.7m to £19.0m (Net debt / Adjusted EBITDA reduced from 4.0x to 1.2x)
·      Basic EPS of 9p and adjusted EPS of 12p
·      Final dividend proposed of 4p per ordinary share giving a total of 6p per ordinary share for the full year
 
Operational Highlights
 
·      Successful maiden full year as a publicly listed company, with a solid trading performance
·      New contract wins have seen market share grow to over 50% of the Discount Sector
·      Good progress made in building a platform for future growth
·      Key new hires to operations and management functions
·      Opened new 168,000 sq. ft. manufacturing facility at Leyland, Lancashire, with two tissue converting lines commissioned and a third line expected in FY18
·      Supply Chain Optimisation plan implemented to improve and simplify warehousing and logistics through a 368,000 sq ft. central warehouse at Skelmersdale and managed by NFT Distribution
 
Steve Crossley, Chief Executive Officer of Accrol, commented:
"This has been a year of positive change for Accrol as we have transitioned to life as an AIM listed company. We have won new contracts and increased our share of the Discount Sector to over 50%."
 
"We continue to build a platform for future growth, having made a significant investment in our new manufacturing facility at Leyland to create extra capacity. A new finished goods warehouse in Skelmersdale, announced in May 2017, will provide central storage and distribution facilities for our customers, improving our supply chain efficiency and enabling us to build on our market position."
 
"Increasing input costs, driven by exchange rates, are impacting most product categories in UK retail and like all UK manufacturers, we continue to seek inflation recovery. There are positive signs, with some retailers increasing consumer price points, although it is slower than we expected. We believe that as price increases come through fully in the market, this will continue to drive shoppers to seek good value in the Discount and Multiple own-label sectors.''
Note 1: Non-GAAP measures are reconciled in note 25
 
There will be an analyst presentation to discuss the results at 9am on 10th July 2017 at the offices of Camarco. Analysts interested in attending should contact Kimberley Taylor on +44 203 757 4999.
 
The Company's annual report for the year ended 30 April 2017 (including notice of the annual general meeting to be held at Accrol's Head Office in Blackburn on 6th October 2017 at 2pm) (the "Annual Report") will shortly be available for downloading from the Company's web site at http://www.accrol.co.uk/investor-relations/.

08:40 10/07/2017
Broker Forecast - Liberum Capital issues a broker note on Accrol Group Hldgs Plc
Liberum Capital today initiates coverage of Accrol Group Hldgs Plc (LON:ACRL) with a buy investment rating and price target of 200p. Story provided by StockMarketWire.com

Someone elsewhere mentioned that this stock is tipped in Shares magazine this week. Not seen it myself.

Full page (page12 ) juzzle

Simon Thompson on investor's chronicle wrote, in answer to a reader comment the other day, that "I am publishing an update on Accrol on Monday 24 July."

(posted by glawsiain elsewhere)

Thanks, will e interesting to read. Shares seems to think there will be plenty of upside.

Haven't seen that Simon Thompson update yet. Not among this latest search on Google News: Accrol news

EDIT: I found this analysis of Accrol's Return On Equity interesting: R-o-E, Accrol

cheers juzzle

ST of IC run profits. Was going to buy back in, on hold for now.

Posting of Accounts & Notice of AGM - Date change
RNS
RNS Number : 4577N
Accrol Group Holdings PLC
09 August 2017
 
9 August 2017
 
Accrol Group Holdings plc (the "Company" or "Accrol")
Posting of Accounts and Notice of AGM - change of dates
 
Further to the announcement of the Preliminary Results on 10 July 2017, the Company announces that it has today posted its Annual Accounts for the year ended 30 April 2017 together with a Notice of Annual General Meeting ("AGM") to its shareholders and that copies are available on the Company's website, www. Accrol.co.uk. The AGM of the Company will be held sooner than previously notified and will now be on 22 September at 10.00am. The venue remains as Accrol's Head office in Blackburn.
 
At the AGM the final dividend of 4 pence per ordinary share will be proposed. Subject to shareholders' approval, this dividend will be paid on 26 September 2017 to shareholders on the register on 1 September 2017. The Company's ordinary shares will become ex-dividend on 31 August 2017 (all such dates being earlier than previously notified).

Questor today -

Questor: boring shares are the best – so buy this kitchen-roll maker for its 5.8pc yield

Anyone subscribing to the MoneyAM Level 2 platform please take note that most days it is not reporting the correct Trade High nor Trade Low information and "some days" not reporting the correct Opening Price or Closing Price.

The reason is because MoneyAM's Level 2 system is not correctly sensing the Auto Trades or Ordinary Trades correctly so is wrongly reporting them

There's a shock then even suspension of trading , never expected anything like that , never bought these thankfully .

I did !

Wonder how big the fine will be given they fear its' materiality - and alongside that - how poor must management have been to allow this to happen?

I did too and made money and took dividends

I sold in two halves so no damage from this, but feel for other shareholders, seemed like a great company, and was even considering buying back in, but really don't care what the price will be when it (or if) it starts trading again, as they say, I'm out (and for good)

Hope it does all work out for them, and the staff and other shareholders.

Same here Steve. They seem to have reversed the results announced on the 10 July (only 3 months since the announcement and and 6 months into a new year)

From Shares -

Accrol’s maiden results for the year to April (10 Jul) revealed a 58% surge in adjusted pre-tax profit to £13m on sales up 14.2% to £135.1m

Dreamcatcher, I have to admit I was both surprised and disappointed, I know the company from a professional point of view (haven't used them though for over 12 months which I suppose should have told me something"!) however never saw this coming, but there you go over and out!

Onto the next which is proving tricky as the ones on my list I either already own, or are looking toppy, love the research, even more now the nights are getting dark earlier

If you come up with any Shares like Fevertree or Wandisco let me know. :-))

Now that would be nice.

My latest three were Taptica, XLM and RPC, but I did get in a couple of weeks ago, and they are doing quite nicely thank you

Also Royal Dutch Shell, that has flown the last few days, its a tough one to either take the profit on this, or just keep long term while the dividend is so good so capital growth and dividend, choices, choices!

Not recommending anything though DYOR as they say.......

Steve - XLM and TAP are among mine too, on my 'Portfolio 69' thread (69) along with IQE, LTG and half a dozen others ;-)

I bought ACRL into that portfolio in July, but luckily ditched it quite quickly having become doubtful in the first two weeks (as posted there, posts 5 and 20, sold Aug 8 for a 9% loss).